ArticleObesity surgery2025
Banded One Anastomosis Gastric Bypass: 15 Year Results from a Single Centre.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBanded one anastomosis gastric bypass (BOAGB) is an efficacious surgical option for patients with obesity. OAGB has a high percentage excess weight loss reported in the literature, and the addition of a silastic ring (SR) otherwise known as a band, helps to reduce recurrent weight gain.
methods156 patients from a single centre between 2005-2008 underwent a BOAGB. A questionnaire, blood test results and electronic records were utilised at 15 years post-operatively to identify patient outcomes.
resultsAt 15 years, the average percentage excess weight loss (%EWL) was 82.0%, the average percentage total weight loss (%TWL) was 35.9%, and the average body mass index (BMI) had reduced from 46.3 kg/m
conclusionsBOAGB continues to show good results as an effective operation at 15 years, with a high %EWL and %TWL, low conversion rate, and significant reduction in medication use for hypertension, hyperlipidaemia, and T2D. There was an increase in proton pump inhibitor use at 15 years. The operation is durable and weight loss remains excellent. The addition of a SR is effective in reducing long-term recurrent weight gain.
Indexed as
Identifiers
40249418What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.